FR3062287B1 - Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques - Google Patents

Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques Download PDF

Info

Publication number
FR3062287B1
FR3062287B1 FR1770087A FR1770087A FR3062287B1 FR 3062287 B1 FR3062287 B1 FR 3062287B1 FR 1770087 A FR1770087 A FR 1770087A FR 1770087 A FR1770087 A FR 1770087A FR 3062287 B1 FR3062287 B1 FR 3062287B1
Authority
FR
France
Prior art keywords
composition
probiotic
nutritional
manufacture
well
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1770087A
Other languages
English (en)
Other versions
FR3062287A1 (fr
Inventor
Benjamin Abrat
Nicolas Pradignac
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
DENALI PHARMA
Original Assignee
DENALI PHARMA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by DENALI PHARMA filed Critical DENALI PHARMA
Priority to FR1770087A priority Critical patent/FR3062287B1/fr
Publication of FR3062287A1 publication Critical patent/FR3062287A1/fr
Application granted granted Critical
Publication of FR3062287B1 publication Critical patent/FR3062287B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne une composition probiotique nutritionnelle comprenant un mélange de 2 souches bactériennes vivantes Lactobacillus rhamnosus GG et Bifidobacterium lactis, ainsi que l'utilisation d'une telle composition pour la fabrication d'un supplément de probiotiques destiné à être administré à la femme enceinte ou allaitante pour optimiser le microbiote intestinal de la mère ainsi que le microbiote placentaire dans lequel son fœtus évolue, et influer positivement sur la santé du futur enfant en réduisant le risque qu'il développe dans ses premières années des troubles atopiques.
FR1770087A 2017-01-27 2017-01-27 Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques Active FR3062287B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR1770087A FR3062287B1 (fr) 2017-01-27 2017-01-27 Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1770087A FR3062287B1 (fr) 2017-01-27 2017-01-27 Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques
FR1770087 2017-01-27

Publications (2)

Publication Number Publication Date
FR3062287A1 FR3062287A1 (fr) 2018-08-03
FR3062287B1 true FR3062287B1 (fr) 2021-07-16

Family

ID=59153191

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1770087A Active FR3062287B1 (fr) 2017-01-27 2017-01-27 Composition probiotique nutritionnelle et utilisation d'une telle composition pour la fabrication d'un supplement de probiotiques

Country Status (1)

Country Link
FR (1) FR3062287B1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104080465A (zh) * 2012-01-13 2014-10-01 科.汉森有限公司 用于预防或治疗上呼吸道感染的鼠李糖乳杆菌和动物双歧杆菌乳亚种
CN106659222A (zh) * 2014-08-08 2017-05-10 雀巢产品技术援助有限公司 肌醇和益生菌及其用途

Also Published As

Publication number Publication date
FR3062287A1 (fr) 2018-08-03

Similar Documents

Publication Publication Date Title
Dominguez-Bello et al. Role of the microbiome in human development
Ferretti et al. Mother-to-infant microbial transmission from different body sites shapes the developing infant gut microbiome
Oikonomou et al. Milk microbiota: what are we exactly talking about?
McGuire et al. Got bacteria? The astounding, yet not-so-surprising, microbiome of human milk
Kumar et al. Distinct patterns in human milk microbiota and fatty acid profiles across specific geographic locations
West et al. Probiotics for treatment and primary prevention of allergic diseases and asthma: looking back and moving forward
Maldonado-Lobón et al. Lactobacillus fermentum CECT 5716 reduces Staphylococcus load in the breastmilk of lactating mothers suffering breast pain: A randomized controlled trial
de Sousa Moraes et al. Intestinal microbiota and probiotics in celiac disease
Bode et al. It's alive: microbes and cells in human milk and their potential benefits to mother and infant
Elias et al. Are probiotics safe for use during pregnancy and lactation?
BR112018075625A2 (pt) composição nutricional compreendendo um probiótico para a prevenção e/ou tratamento de distúrbios de ansiedade e condições relacionadas em um mamífero
SI1565547T1 (sl) Probiotiäśni sevi, postopek za izbiranje le-teh, njihovi sestavki in njihova uporaba
Colella et al. Microbiota revolution: How gut microbes regulate our lives
MA43488A1 (fr) Utilisation de probiotiques dans le traitement et/ou la prevention du psoriasis
EA201390305A1 (ru) Композиции для влагалищного и перорального введения lactobacillus и их применение
PH12017502182A1 (en) Nutritional compositions and infant formulas comprising bifidobacterium animalis ssp. lactis and optionally a mix of oligosaccharides for inducing a gut microbiota close to the one of breast fed infants
MA44893A1 (fr) Utilisation de probiotiques dans le traitement et/ou la prévention de la dermatite atopique
MX2019005343A (es) Composiciones nutricionales que proporcionan manejo dietetico de colicos.
WO2015177246A3 (fr) Supplémentation en microbiome néonatal
Bedaiwi et al. Microbiome and probiotics: link to arthritis
PH12019500799A1 (en) Personalized pediatric nutrition products comprising human milk oligosaccharides
CA2602693A1 (fr) Espece bifidobacterienne probiotique
Herman Probiotics supplementation in prophylaxis and treatment of depressive and anxiety disorders-a review of current research
Zhao et al. Prevention of atopic dermatitis in mice by Lactobacillus reuteri Fn041 through induction of regulatory T cells and modulation of the gut microbiota
Rodríguez et al. Infectious mastitis during lactation: a mammary dysbiosis model

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20180803

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6

PLFP Fee payment

Year of fee payment: 7

PLFP Fee payment

Year of fee payment: 8